Table 4.
A. Cohort 1 (n=63) | |||||
---|---|---|---|---|---|
Event | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Total |
Fatigue | 54 (86%) | 3(5%) | 0 (0%) | 0 (0%) | 57 (91%) |
Hot flashes | 37 (59%) | 4 (6%) | 0 (0%) | 0 (0%) | 41 (65%) |
Neuropathy | 26 (41%) | 0 (0%) | 0 (0%) | 0 (0%) | 26 (41%) |
Febrile Neutropenia | 0 (0%) | 0 (0%) | 4 (6%) | 5 (8%) | 9 (14%) |
Neutropenia | 1 (2%) | 3 (5%) | 9 (14%) | 28 (44%) | 41 (65%) |
Hyperglycemia | 15 (24%) | 25 (40%) | 14 (22%) | 0 (0%) | 54 (86%) |
Mental Status Change | 0 (0%) | 0 (0%) | 1 (1.6%) | 0 (0%) | 1 (1.6%) |
B. Cohort 2 (n=39) | |||||
---|---|---|---|---|---|
Event | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Total |
Fatigue | 33 (85%) | 5 (13%) | 0 (0%) | 0 (0%) | 38 (98%) |
Hot flashes | 29 (74%) | 1 (3%) | 0 (0%) | 0 (0%) | 30 (77%) |
Neuropathy | 23 (59%) | 2 (5%) | 0 (0%) | 0 (0%) | 25 (64%) |
Febrile Neutropenia | 0 (0%) | 0 (0%) | 6 (15%) | 1 (3%) | 7 (18%) |
Neutropenia | 0 (0%) | 5 (13%) | 6 (15%) | 16 (41%) | 27 (70%) |
Hyperglycemia | 10 (26%) | 20 (51%) | 8 (21%) | 0 (0%) | 38 (98%) |